Tomo-Seq Identifies SOX9 as a Key Regulator of Cardiac Fibrosis During Ischemic Injury | Zendy

Grégory Lacraz | Zendy; Jan Philipp Junker | Zendy; Monika M Gladka | Zendy; Bas Molenaar | Zendy; Koen T. Scholman | Zendy; Marta VigilGarcia | Zendy; Daniëlle Versteeg | Zendy; Hesther de Ruiter | Zendy; Marit W. Vermunt | Zendy; Menno P. Creyghton | Zendy; Ma M. H. Huibers | Zendy; Nicolaas de Jonge | Zendy; Alexander van Oudenaarden | Zendy; Eva van Rooij | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Tomo-Seq Identifies SOX9 as a Key Regulator of Cardiac Fibrosis During Ischemic Injury

Author(s) -

Grégory Lacraz,

Jan Philipp Junker,

Monika M Gladka,

Bas Molenaar,

Koen T. Scholman,

Marta VigilGarcia,

Daniëlle Versteeg,

Hesther de Ruiter,

Marit W. Vermunt,

Menno P. Creyghton,

Ma M. H. Huibers,

Nicolaas de Jonge,

Alexander van Oudenaarden,

Eva van Rooij

Publication year - 2017

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.117.027832

Subject(s) - fibrosis , transcriptome , heart failure , medicine , regulator , cardiac fibrosis , transcriptional regulation , gene , gene expression , biology , computational biology , bioinformatics , pathology , genetics

Cardiac ischemic injury induces a pathological remodeling response, which can ultimately lead to heart failure. Detailed mechanistic insights into molecular signaling pathways relevant for different aspects of cardiac remodeling will support the identification of novel therapeutic targets.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research